KemPharm, Inc. (KMPH) financial statements (2022 and earlier)

Company profile

Business Address 1180 CELEBRATION BOULEVARD, SUITE 103
CELEBRATION, FL 34747
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments112,3464,2133,21721,66942,22967,76551,320
Cash and cash equivalents112,3464,2133,21718,40910,87116,76232,318
Short-term investments   3,26031,35851,00319,002
Restricted cash and investments 109  1,1001,100 
Receivables1,5282,5791,8651402,0815,0612,375
Prepaid expense637453250224202333290
Capitalized contract cost  805 
Deferred costs293825266    
Other undisclosed current assets2522032311,6881,3849893
Total current assets:115,0568,3826,63423,72146,99674,35754,078
Noncurrent Assets
Operating lease, right-of-use asset1,1411,3501,537
Property, plant and equipment8841,0391,4711,7532,0041,970403
Long-term investments and receivables15,422   3,2508,200 
Long-term investments15,422   3,2508,200 
Regulated entity, other noncurrent assets      1,133
Restricted cash and investments  338710   
Other noncurrent assets438438527562206360109
Total noncurrent assets:17,8852,8273,8733,0255,46010,5301,645
TOTAL ASSETS:132,94111,20910,50726,74652,45684,88755,723
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,0386,6474,9118,3427,8756,4444,906
Accounts payable5161,1741,1403,7152,1774691,252
Accrued liabilities700700700700700700700
Employee-related liabilities1,0541,29917311,1181,024947
Interest and dividends payable 1,1583591,9212,2222,222698
Other undisclosed accounts payable and accrued liabilities7682,3162,7111,2751,6582,0291,309
Debt 3902843,5473,5221573,436
Other liabilities83617223611511241 
Other undisclosed current liabilities356327     
Total current liabilities:4,2307,5365,43112,00411,5096,6428,342
Noncurrent Liabilities
Long-term debt and lease obligation1,23269,63679,24478,50189,96091,17019,663
Long-term debt, excluding current maturities 68,04977,34378,10589,39891,17019,663
Capital lease obligations396562  
Operating lease, liability1,2321,5871,901
Liabilities, other than long-term debt311451686897941,153 
Other liabilities311451686897941,153 
Other undisclosed noncurrent liabilities3303041202,1187,7094,61837,839
Total noncurrent liabilities:1,59370,08579,53281,30898,46396,94157,502
Total liabilities:5,82377,62184,96393,312109,972103,58365,844
Stockholders' equity
Stockholders' equity attributable to parent127,118(66,412)(74,456)(66,566)(57,516)(18,696)(10,121)
Common stock4 43111
Treasury stock, value(2,814)      
Additional paid in capital396,957192,062171,254154,623107,209102,64394,702
Accumulated deficit(267,029)(258,474)(245,714)(221,192)(164,726)(121,340)(104,824)
Total stockholders' equity:127,118(66,412)(74,456)(66,566)(57,516)(18,696)(10,121)
TOTAL LIABILITIES AND EQUITY:132,94111,20910,50726,74652,45684,88755,723

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues28,65013,28812,839    
Cost of revenue(1,930)(1,181)(10,000)    
Cost of goods and services sold  (10,000)    
Gross profit:26,72012,1072,839    
Operating expenses(18,991)(17,716)(30,231)(55,903)(33,366)(37,482)(22,814)
Other undisclosed operating income  7,055    
Operating income (loss):7,729(5,609)(20,337)(55,903)(33,366)(37,482)(22,814)
Nonoperating income (expense)(16,250)(7,185)(4,207)(689)(10,063)20,951(31,824)
Interest and debt expense(16,096)(4,785)(4,858)2(5,776)(4,740)(2,671)
Loss from continuing operations before equity method investments, income taxes:(24,617)(17,579)(29,402)(56,590)(49,205)(21,271)(57,309)
Other undisclosed income (loss) from continuing operations before income taxes16,0964,7854,858(2)5,7764,7402,671
Loss from continuing operations before income taxes:(8,521)(12,794)(24,544)(56,592)(43,429)(16,531)(54,638)
Income tax expense (benefit)(34)34221264315(26)
Net loss attributable to parent:(8,555)(12,760)(24,522)(56,466)(43,386)(16,516)(54,664)
Preferred stock dividends and other adjustments(54,342)      
Net loss available to common stockholders, basic:(62,897)(12,760)(24,522)(56,466)(43,386)(16,516)(54,664)
Other undisclosed net loss available to common stockholders, diluted(26)      
Net loss available to common stockholders, diluted:(62,923)(12,760)(24,522)(56,466)(43,386)(16,516)(54,664)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(8,555)(12,760)(24,522)(56,466)(43,386)(16,516)(54,664)
Comprehensive loss, net of tax, attributable to parent:(8,555)(12,760)(24,522)(56,466)(43,386)(16,516)(54,664)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: